ATRA Forex Haberleri
Atara Biotherapeutics Says Carol Gallagher To Replace Ron Renaud As Chair Of The Board Of Directors
Atara Biotherapeutics, Inc. (ATRA) announced Monday that Carol Gallagher will assume the role of Chair of the Board of Directors, replacing Ron Renaud, who is stepping down to focus on his new position as Managing Director at Bain Capital Life Sciences.
RTTNews
|
777 gün önce
Atara's Ebvallo Receives European Commission Approval For Adults And Children With EBV+ PTLD
Atara Biotherapeutics, Inc. (ATRA) and French healthcare company Pierre Fabre announced Monday that the European Commission (EC) has granted marketing authorization for Ebvallo (tabelecleucel) as a monotherapy for the treatment of adult and pediatric patients two years of age and older with relapsed or refractory Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD) who have received at least one prior therapy.
RTTNews
|
777 gün önce
